Optain Health, a healthcare technology company applying artificial intelligence (AI), robotic retinal imaging, and teleophthalmology to detect eye and systemic disease earlier, announced the close of an oversubscribed $26 million Series A. The raise was led by global software investor Insight Partners with participation from existing investors.

Additional investors, including Informed Ventures, Lumio Capital, Meridian Ventures, and the UniQuest Extension Fund will accelerate the growth of Optain's global footprint in Australia, Europe, the Middle East, and Southeast Asia.